Development of floating microspheres to improve oral bioavalibity of cefpodoxime proxetil

Acta Pharmaceutica Sciencia

Volumn 52, Issue 1, 2010, Pages 101-104

  Karthikeyan, Deepa ^a   Karthikeyan, M ^b   Ramasamy, C ^c  

^a Nehru College of Pharmacy   (India)

^b AL SHIFA COLLEGE OF PHARMACY   (India)

^c Jamia Salafiyya College of pharmacy   (India)

Author keywords

Bioavailability; Cefpodoxime proxetil; Ethyl cellulose; Floating microspheres; Hydroxyl propyl methyl cellulose; In vitro release studies

Indexed keywords

CEFPODOXIME PROXETIL; ETHYL CELLULOSE; HYDROXYPROPYLMETHYLCELLULOSE; MICROSPHERE; POLYSORBATE 80;

ARTICLE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG FORMULATION; DRUG MIXTURE; DRUG RELEASE; EVAPORATION; ORAL DRUG ADMINISTRATION; PARTICLE SIZE; STOMACH ABSORPTION; VISCOSITY;

EID: 77954236151     PISSN: 13072080     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Asha, P., Subhabrata, R. and Ram, S.T. (2006). In vitro evaluation and optimization of controlled release floating drug delivery system of metformin hydrochloride. DARU, 14: 57-64.
2. Gerogianis, V.S., Rekkas, D.M., Dallas, P.P. and Choulis, N.H. (1993). Floating and swelling characteristic of various excipients used in controlled release technology. Drug Dev. Ind. Pharm. 19: 1061-1081.
3. Sader, H.S., Jones, R.N., Washington, J.A., Murray, P.R., Gerlach, E.H., Allen, S.D. and Erwin, M. E. (1993). In vitro activity of Cefpodoxime compared with other oral cefphalosporins tested against 5556 recent clinical isolates from five medical center. Diagn. Microbiol. Infect. Dis. 17: 143-150.
4. Srivastava, A.K., Devendra, N.R. and Saurabh, W. (2005). Floating microspheres of Cimetidine: formulation, characterization and in vitro evaluation. Acta Pharm. 55: 227-285.
5. Sylvie, C.M., Denis, B., Marie, O.D., Robert, F. and Jean-Claude, C. (1998). Cefpodoxime-Proxetil protection from intestinal lumen hydrolysis by oil-in-water submicron emulsions. Int. J. Pharm.165: 97-106.
6. Vasu, K.K., Vinod, A. and Arvind, K.B. (2006). Investigation of factors responsible for low oral bioavailability of Cefpodoxime proxetil. Int. J. Pharm. 317: 155-160.